000 | 01748 a2200481 4500 | ||
---|---|---|---|
005 | 20250517200846.0 | ||
264 | 0 | _c20190117 | |
008 | 201901s 0 0 eng d | ||
022 | _a1878-5875 | ||
024 | 7 |
_a10.1016/j.biocel.2018.01.016 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHu, Yun-Ping | |
245 | 0 | 0 |
_aSTYK1 promotes cancer cell proliferation and malignant transformation by activating PI3K-AKT pathway in gallbladder carcinoma. _h[electronic resource] |
260 |
_bThe international journal of biochemistry & cell biology _c04 2018 |
||
300 |
_a16-27 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aCell Proliferation |
650 | 0 | 4 |
_aCell Transformation, Neoplastic _xgenetics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGallbladder Neoplasms _xenzymology |
650 | 0 | 4 |
_aHeterocyclic Compounds, 3-Ring _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aNeoplasm Metastasis |
650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xgenetics |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xantagonists & inhibitors |
650 | 0 | 4 |
_aReceptor Protein-Tyrosine Kinases _xgenetics |
650 | 0 | 4 | _aSignal Transduction |
700 | 1 | _aWu, Zeng-Bin | |
700 | 1 | _aJiang, Lin | |
700 | 1 | _aJin, Yun-Peng | |
700 | 1 | _aLi, Huai-Feng | |
700 | 1 | _aZhang, Yi-Jian | |
700 | 1 | _aMa, Qiang | |
700 | 1 | _aYe, Yuan-Yuan | |
700 | 1 | _aWang, Zheng | |
700 | 1 | _aLiu, Yong-Chen | |
700 | 1 | _aChen, Hong-Zhuan | |
700 | 1 | _aLiu, Ying-Bin | |
773 | 0 |
_tThe international journal of biochemistry & cell biology _gvol. 97 _gp. 16-27 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.biocel.2018.01.016 _zAvailable from publisher's website |
999 |
_c28056997 _d28056997 |